Amphastar Pharmaceuticals Cost of Goods Sold 2012-2024 | AMPH
Amphastar Pharmaceuticals cost of goods sold from 2012 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Amphastar Pharmaceuticals Annual Cost of Goods Sold
(Millions of US $) |
| 2023 |
$293 |
| 2022 |
$250 |
| 2021 |
$238 |
| 2020 |
$207 |
| 2019 |
$190 |
| 2018 |
$188 |
| 2017 |
$150 |
| 2016 |
$151 |
| 2015 |
$174 |
| 2014 |
$159 |
| 2013 |
$143 |
| 2012 |
$114 |
| 2011 |
$90 |
| 2009 |
$36 |
Amphastar Pharmaceuticals Quarterly Cost of Goods Sold
(Millions of US $) |
| 2024-09-30 |
$89 |
| 2024-06-30 |
$87 |
| 2024-03-31 |
$82 |
| 2023-12-31 |
$82 |
| 2023-09-30 |
$72 |
| 2023-06-30 |
$73 |
| 2023-03-31 |
$66 |
| 2022-12-31 |
$64 |
| 2022-09-30 |
$62 |
| 2022-06-30 |
$60 |
| 2022-03-31 |
$65 |
| 2021-12-31 |
$65 |
| 2021-09-30 |
$61 |
| 2021-06-30 |
$54 |
| 2021-03-31 |
$58 |
| 2020-12-31 |
$59 |
| 2020-09-30 |
$47 |
| 2020-06-30 |
$53 |
| 2020-03-31 |
$48 |
| 2019-12-31 |
$50 |
| 2019-09-30 |
$45 |
| 2019-06-30 |
$47 |
| 2019-03-31 |
$49 |
| 2018-12-31 |
$55 |
| 2018-09-30 |
$46 |
| 2018-06-30 |
$45 |
| 2018-03-31 |
$41 |
| 2017-12-31 |
$40 |
| 2017-09-30 |
$37 |
| 2017-06-30 |
$38 |
| 2017-03-31 |
$34 |
| 2016-12-31 |
$44 |
| 2016-09-30 |
$37 |
| 2016-06-30 |
$36 |
| 2016-03-31 |
$34 |
| 2015-12-31 |
$44 |
| 2015-09-30 |
$46 |
| 2015-06-30 |
$41 |
| 2015-03-31 |
$44 |
| 2014-12-31 |
$44 |
| 2014-09-30 |
$48 |
| 2014-06-30 |
$34 |
| 2014-03-31 |
$33 |
| 2013-12-31 |
$35 |
| 2013-09-30 |
$39 |
| 2013-06-30 |
$35 |
| 2013-03-31 |
$33 |
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.294B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
